{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:43:44Z","timestamp":1791225824783,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.coph.2016.11.007","type":"journal-article","created":{"date-parts":[[2016,12,6]],"date-time":"2016-12-06T20:01:07Z","timestamp":1481054467000},"page":"77-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":127,"special_numbering":"C","title":["Biased mu-opioid receptor ligands: a promising new generation of pain therapeutics"],"prefix":"10.1016","volume":"32","author":[{"given":"Edward R","family":"Siuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Richard","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H","family":"Rominger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D","family":"Violin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2016.11.007_bib0380","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0531-5131(02)00699-4","article-title":"Pain relief and sedation in Roman Byzantine texts: Mandragoras officinarum, Hyoscyamos niger and Atropa belladonna","volume":"1242","author":"Ramoutsaki","year":"2002","journal-title":"Int Congr Ser"},{"issue":"Suppl. 17","key":"10.1016\/j.coph.2016.11.007_bib0385","doi-asserted-by":"publisher","first-page":"S133","DOI":"10.5301\/JN.2011.6481","article-title":"Development of the concept of pain in history","volume":"24","author":"Santoro","year":"2011","journal-title":"J Nephrol"},{"key":"10.1016\/j.coph.2016.11.007_bib0390","series-title":"World Health Organ Tech Rep Ser","first-page":"vii","article-title":"The selection and use of essential medicines","author":"Medicines","year":"2015"},{"key":"10.1016\/j.coph.2016.11.007_bib0395","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1126\/science.179.4077.1011","article-title":"Opiate receptor: demonstration in nervous tissue","volume":"179","author":"Pert","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.coph.2016.11.007_bib0400","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1046\/j.1460-9568.2003.02482.x","article-title":"Acute antinociceptive responses in single and combinatorial opioid receptor knockout mice: distinct mu, delta and kappa tones","volume":"17","author":"Martin","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.coph.2016.11.007_bib0405","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/383819a0","article-title":"Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene","volume":"383","author":"Matthes","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.coph.2016.11.007_bib0410","first-page":"502","article-title":"The inhibitory effect of fentanyl and other morphine-like analgesics on the warm water induced tail withdrawal reflex in rats","volume":"13","author":"Janssen","year":"1963","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.coph.2016.11.007_bib0415","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2165\/00003495-197917020-00001","article-title":"Buprenorphine: a review of its pharmacological properties and therapeutic efficacy","volume":"17","author":"Heel","year":"1979","journal-title":"Drugs"},{"key":"10.1016\/j.coph.2016.11.007_bib0420","first-page":"135","article-title":"General pharmacological studies on tramadol, a potent analgetic agent (author's transl)","volume":"28","author":"Osterloh","year":"1978","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.coph.2016.11.007_bib0425","doi-asserted-by":"publisher","first-page":"R5","DOI":"10.1016\/0014-2999(94)90073-6","article-title":"G-protein antisense oligodeoxyribonucleotides and mu-opioid supraspinal antinociception","volume":"258","author":"Raffa","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.coph.2016.11.007_bib0430","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0361-9230(00)00448-2","article-title":"Agonists determine the pattern of G-protein activation in mu-opioid receptor-mediated supraspinal analgesia","volume":"54","author":"Sanchez-Blazquez","year":"2001","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.coph.2016.11.007_bib0435","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1523\/JNEUROSCI.4899-04.2005","article-title":"Spinal G-protein-gated potassium channels contribute in a dose-dependent manner to the analgesic effect of mu- and delta- but not kappa-opioids","volume":"25","author":"Marker","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.coph.2016.11.007_bib0440","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1073\/pnas.93.4.1486","article-title":"Determinants of the G protein-dependent opioid modulation of neuronal calcium channels","volume":"93","author":"Bourinet","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2016.11.007_bib0445","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/35047086","article-title":"Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence","volume":"408","author":"Bohn","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.coph.2016.11.007_bib0450","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1124\/jpet.105.087254","article-title":"Morphine side effects in beta-arrestin 2 knockout mice","volume":"314","author":"Raehal","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.coph.2016.11.007_bib0455","doi-asserted-by":"publisher","first-page":"31731","DOI":"10.1074\/jbc.M111.248310","article-title":"Agonist-directed interactions with specific beta-arrestins determine mu-opioid receptor trafficking, ubiquitination, and dephosphorylation","volume":"286","author":"Groer","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2016.11.007_bib0460","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1126\/science.286.5449.2495","article-title":"Enhanced morphine analgesia in mice lacking beta-arrestin 2","volume":"286","author":"Bohn","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.coph.2016.11.007_bib0465","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1126\/science.1063866","article-title":"Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin","volume":"294","author":"Shenoy","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.coph.2016.11.007_bib0470","doi-asserted-by":"publisher","first-page":"6650","DOI":"10.1073\/pnas.0901083106","article-title":"Beta-arrestin-dependent signaling and trafficking of 7-transmembrane receptors is reciprocally regulated by the deubiquitinase USP33 and the E3 ligase Mdm2","volume":"106","author":"Shenoy","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2016.11.007_bib0475","doi-asserted-by":"publisher","first-page":"4887","DOI":"10.1128\/MCB.05690-11","article-title":"Beta-arrestin2 plays permissive roles in the inhibitory activities of RGS9-2 on G protein-coupled receptors by maintaining RGS9-2 in the open conformation","volume":"31","author":"Zheng","year":"2011","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.coph.2016.11.007_bib0480","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1074\/jbc.M506576200","article-title":"Beta-arrestin-dependent, G protein-independent ERK1\/2 activation by the beta2 adrenergic receptor","volume":"281","author":"Shenoy","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2016.11.007_bib0485","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1126\/science.283.5402.655","article-title":"Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes","volume":"283","author":"Luttrell","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.coph.2016.11.007_bib0490","doi-asserted-by":"publisher","first-page":"15903","DOI":"10.1074\/jbc.M710006200","article-title":"The beta-arrestin-2 scaffold protein promotes c-Jun N-terminal kinase-3 activation by binding to its nonconserved N terminus","volume":"283","author":"Guo","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2016.11.007_bib0495","doi-asserted-by":"publisher","first-page":"18081","DOI":"10.1074\/jbc.M513640200","article-title":"Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes","volume":"281","author":"Bruchas","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2016.11.007_bib0500","doi-asserted-by":"publisher","first-page":"17201","DOI":"10.1074\/jbc.M910348199","article-title":"Differential affinities of visual arrestin, beta arrestin1, and beta arrestin2 for G protein-coupled receptors delineate two major classes of receptors","volume":"275","author":"Oakley","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2016.11.007_bib0505","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1124\/mol.66.1.106","article-title":"Relative opioid efficacy is determined by the complements of the G protein-coupled receptor desensitization machinery","volume":"66","author":"Bohn","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.coph.2016.11.007_bib0510","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1124\/jpet.110.173948","article-title":"Functional selectivity and biased receptor signaling","volume":"336","author":"Kenakin","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.coph.2016.11.007_sbref0515","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrd3954","article-title":"Signalling bias in new drug discovery: detection, quantification and therapeutic impact","volume":"12","author":"Kenakin","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.coph.2016.11.007_bib0520","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ceb.2013.10.008","article-title":"Recent developments in biased agonism","volume":"27","author":"Wisler","year":"2014","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.coph.2016.11.007_bib0525","doi-asserted-by":"publisher","first-page":"19478","DOI":"10.1074\/jbc.R115.662759","article-title":"Novel allosteric modulators of G protein-coupled receptors","volume":"290","author":"Gentry","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2016.11.007_bib0530","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.tips.2007.06.006","article-title":"Beta-arrestin-biased ligands at seven-transmembrane receptors","volume":"28","author":"Violin","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.coph.2016.11.007_bib0535","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.str.2012.05.010","article-title":"Ligand-specific interactions modulate kinetic, energetic, and mechanical properties of the human beta2 adrenergic receptor","volume":"20","author":"Zocher","year":"2012","journal-title":"Structure"},{"key":"10.1016\/j.coph.2016.11.007_bib0540","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.6b00367","article-title":"Molecular mechanism of biased ligand conformational changes in CC chemokine receptor 7","author":"Gaieb","year":"2016","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.coph.2016.11.007_sbref0545","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.cell.2015.04.043","article-title":"Structural insights into the dynamic process of beta2-adrenergic receptor signaling","volume":"161","author":"Manglik","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.coph.2016.11.007_bib0550","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1126\/science.1215802","article-title":"Biased signaling pathways in beta2-adrenergic receptor characterized by 19F-NMR","volume":"335","author":"Liu","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.coph.2016.11.007_bib0555","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1098\/rspb.1983.0093","article-title":"Operational models of pharmacological agonism","volume":"220","author":"Black","year":"1983","journal-title":"Proc R Soc Lond B Biol Sci"},{"key":"10.1016\/j.coph.2016.11.007_bib0560","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00210-008-0260-4","article-title":"On the analysis of ligand-directed signaling at G protein-coupled receptors","volume":"377","author":"Ehlert","year":"2008","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.coph.2016.11.007_bib0565","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.bcp.2016.05.014","article-title":"Systematic analysis of factors influencing observations of biased agonism at the mu-opioid receptor","volume":"113","author":"Thompson","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.coph.2016.11.007_bib0570","doi-asserted-by":"publisher","first-page":"1ra1","DOI":"10.1126\/scitranslmed.3000071","article-title":"A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation","volume":"1","author":"Gesty-Palmer","year":"2009","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coph.2016.11.007_bib0575","doi-asserted-by":"publisher","first-page":"16657","DOI":"10.1073\/pnas.0707936104","article-title":"A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling","volume":"104","author":"Wisler","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2016.11.007_bib0580","doi-asserted-by":"publisher","first-page":"14555","DOI":"10.1073\/pnas.0804745105","article-title":"Beta-blockers alprenolol and carvedilol stimulate beta-arrestin-mediated EGFR transactivation","volume":"105","author":"Kim","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2016.11.007_bib0585","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1124\/jpet.110.173005","article-title":"Selectively engaging beta-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance","volume":"335","author":"Violin","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.coph.2016.11.007_sbref0590","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/npp.2015.196","article-title":"Effects of beta-arrestin-biased dopamine D2 receptor ligands on schizophrenia-like behavior in hypoglutamatergic mice","volume":"41","author":"Park","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.coph.2016.11.007_bib0595","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1124\/mol.106.028258","article-title":"An opioid agonist that does not induce mu-opioid receptor\u2014arrestin interactions or receptor internalization","volume":"71","author":"Groer","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.coph.2016.11.007_bib0600","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.drugalcdep.2011.10.026","article-title":"Antinociceptive effects of herkinorin, a MOP receptor agonist derived from salvinorin A in the formalin test in rats: new concepts in mu opioid receptor pharmacology: from a symposium on new concepts in mu-opioid pharmacology","volume":"121","author":"Lamb","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.coph.2016.11.007_bib0605","doi-asserted-by":"publisher","first-page":"8019","DOI":"10.1021\/jm4010829","article-title":"Structure-activity relationships and discovery of a G protein biased mu opioid receptor ligand, [(3-methoxythiophen-2-yl)methyl]({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro-[4.5]decan-9-yl]ethyl})amine (TRV130), for the treatment of acute severe pain","volume":"56","author":"Chen","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.coph.2016.11.007_sbref0610","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1124\/jpet.112.201616","article-title":"A G protein-biased ligand at the mu-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine","volume":"344","author":"DeWire","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.coph.2016.11.007_sbref0615","first-page":"1","article-title":"Structure-based discovery of opioid analgesics with reduced side effects","author":"Manglik","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.coph.2016.11.007_bib0620","doi-asserted-by":"crossref","first-page":"10265","DOI":"10.1523\/JNEUROSCI.23-32-10265.2003","article-title":"Enhanced rewarding properties of morphine, but not cocaine, in beta(arrestin)-2 knock-out mice","volume":"23","author":"Bohn","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.coph.2016.11.007_sbref0625","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b00748","article-title":"Mitragynine\/corynantheidine pseudoindoxyls as opioid analgesics with mu agonism and delta antagonism which do not recruit beta-arrestin-2","author":"Varadi","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.coph.2016.11.007_bib0630","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.neuropharm.2015.12.024","article-title":"Endomorphin analog analgesics with reduced abuse liability, respiratory depression, motor impairment, tolerance, and glial activation relative to morphine","volume":"105","author":"Zadina","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.coph.2016.11.007_bib0635","doi-asserted-by":"publisher","first-page":"954","DOI":"10.3390\/ijms10030954","article-title":"Improvement of morphine-mediated analgesia by inhibition of beta-arrestin 2 expression in mice periaqueductal gray matter","volume":"10","author":"Li","year":"2009","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coph.2016.11.007_bib0640","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.neulet.2006.02.071","article-title":"Decreased morphine analgesia in rat overexpressing beta-arrestin 2 at periaqueductal gray","volume":"400","author":"Jiang","year":"2006","journal-title":"Neurosci Lett"},{"issue":"Pt 6","key":"10.1016\/j.coph.2016.11.007_bib0645","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1113\/jphysiol.2013.258830","article-title":"CrossTalk opposing view: the pre-B\u00f6tzinger complex is not essential for respiratory depression following systemic administration of opioid analgesics","volume":"592","author":"Lalley","year":"2014","journal-title":"J Physiol"},{"issue":"Pt 6","key":"10.1016\/j.coph.2016.11.007_bib0650","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1113\/jphysiol.2013.261974","article-title":"CrossTalk proposal: the preB\u00f6tzinger complex is essential for the respiratory depression following systemic administration of opioid analgesics","volume":"592","author":"Montandon","year":"2014","journal-title":"J Physiol"},{"key":"10.1016\/j.coph.2016.11.007_bib0655","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/0306-4522(92)90261-Y","article-title":"The co-existence of biogenic amines and neuropeptides in the type I cells of the cat carotid body","volume":"47","author":"Wang","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.coph.2016.11.007_bib0660","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/284269a0","article-title":"Enkephalin-, VIP- and substance P-like immunoreactivity in the carotid body","volume":"284","author":"Wharton","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.coph.2016.11.007_bib0665","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/bja\/aen094","article-title":"Opioids and the control of respiration","volume":"100","author":"Pattinson","year":"2008","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.coph.2016.11.007_bib0670","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2014.00186","article-title":"Kir3 channel signaling complexes: focus on opioid receptor signaling","volume":"8","author":"Nagi","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.coph.2016.11.007_bib0675","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1097\/ALN.0000000000000984","article-title":"G-protein-gated inwardly rectifying potassium channels modulate respiratory depression by opioids","volume":"124","author":"Montandon","year":"2016","journal-title":"Anesthesiology"},{"key":"10.1016\/j.coph.2016.11.007_bib0680","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1111\/nmo.12443","article-title":"Site and mechanism of morphine tolerance in the gastrointestinal tract","volume":"26","author":"Akbarali","year":"2014","journal-title":"Neurogastroenterol Motil"},{"issue":"Suppl. 2","key":"10.1016\/j.coph.2016.11.007_bib0685","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1743-3150.2004.00554.x","article-title":"Function of opioids in the enteric nervous system","volume":"16","author":"Wood","year":"2004","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.coph.2016.11.007_bib0690","first-page":"341","article-title":"Effects of intrathecal and intraperitoneal morphine on gastrointestinal motility in the rat","volume":"9","author":"Sugahara","year":"1992","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.coph.2016.11.007_bib0695","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/2040622315627801","article-title":"Opioid-induced constipation: advances and clinical guidance","volume":"7","author":"Nelson","year":"2016","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.coph.2016.11.007_bib0700","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1124\/jpet.113.204313","article-title":"Mechanisms that underlie mu-opioid receptor agonist-induced constipation: differential involvement of mu-opioid receptor sites and responsible regions","volume":"347","author":"Mori","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.coph.2016.11.007_bib0705","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1124\/jpet.111.186320","article-title":"The role of beta-arrestin2 in the mechanism of morphine tolerance in the mouse and guinea pig gastrointestinal tract","volume":"340","author":"Kang","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.coph.2016.11.007_bib0710","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ajgsup.2014.5","article-title":"Molecular physiology of enteric opioid receptors","volume":"2","author":"Galligan","year":"2014","journal-title":"Am J Gastroenterol Suppl"},{"key":"10.1016\/j.coph.2016.11.007_bib0715","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1046\/j.1471-4159.2000.740574.x","article-title":"Mu-opioid agonist inhibition of kappa-opioid receptor-stimulated extracellular signal-regulated kinase phosphorylation is dynamin-dependent in C6 glioma cells","volume":"74","author":"Bohn","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.coph.2016.11.007_bib0720","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1213\/ANE.0000000000000002","article-title":"Consensus guidelines for the management of postoperative nausea and vomiting","volume":"118","author":"Gan","year":"2014","journal-title":"Anesth Analg"},{"key":"10.1016\/j.coph.2016.11.007_bib0725","article-title":"Smart respiratory monitoring: clinical development and validation of the IPI (Integrated Pulmonary Index) algorithm","author":"Ronen","year":"2016","journal-title":"J Clin Monit Comput"},{"key":"10.1016\/j.coph.2016.11.007_bib0730","doi-asserted-by":"publisher","first-page":"e0150214","DOI":"10.1371\/journal.pone.0150214","article-title":"Association of opioids and sedatives with increased risk of in-hospital cardiopulmonary arrest from an administrative database","volume":"11","author":"Overdyk","year":"2016","journal-title":"PLOS ONE"},{"key":"10.1016\/j.coph.2016.11.007_bib0735","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/jcph.207","article-title":"First clinical experience with TRV130: pharmacokinetics and pharmacodynamics in healthy volunteers","volume":"54","author":"Soergel","year":"2014","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.coph.2016.11.007_sbref0740","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/j.pain.2014.06.011","article-title":"Biased agonism of the mu-opioid receptor by TRV130 increases analgesia and reduces on-target adverse effects versus morphine: a randomized, double-blind, placebo-controlled, crossover study in healthy volunteers","volume":"155","author":"Soergel","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.coph.2016.11.007_bib0745","series-title":"American Society of Regional Anesthesia 41st Annual Regional Anesthesiology and Acute Pain Medicine Meeting","article-title":"A randomized, placebo-and active-controlled phase 2b abdominoplasty study investigating oliceridine(TRV130), a novel \u03bc receptor G protein pathway selective (\u03bc-GPS) modulator","author":"Singla","year":"2016"},{"key":"10.1016\/j.coph.2016.11.007_bib0750","unstructured":"BreakthroughTherapies, www.focr.org\/breakthrough-therapies."}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489216301394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489216301394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T04:38:33Z","timestamp":1568608713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489216301394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":75,"alternative-id":["S1471489216301394"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2016.11.007","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biased mu-opioid receptor ligands: a promising new generation of pain therapeutics","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2016.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}